Study finds safest treatment for immunodeficiency disorder is not cost effective for US patients
Patients with a rare immunodeficiency disorder who are treated with lifelong immunoglobulin replacement therapy (IRT) have a lower risk of premature death than patients treated with a hematopoietic stem cell transplant (HSCT), ...
Nov 15, 2021
0
0
